Category: Uncategorized
-
Trikafta predicted to add 33 years to life expectancy
A recent study from the UK has predicted that Trikafta may increase the life expectancy of those aged 12+ with two F508del to a median age of 71.6!! This is +33 years compared to best supportive care and +23 years compared to Symdeko! These findings are based on a microsimulation prediction involving the phase 3…